<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04801290</url>
  </required_header>
  <id_info>
    <org_study_id>BM_84982019</org_study_id>
    <nct_id>NCT04801290</nct_id>
  </id_info>
  <brief_title>TIPS in Patients With Decompensated Liver Cirrhosis</brief_title>
  <official_title>Benefits and Limitations of Transjugular Intrahepatic Portosystemic Shunts (TIPS) in Patients With Decompensated Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center patient registry of patients receiving a transjugular intrahepatic&#xD;
      portosystemic shunt (TIPS) at Hannover Medical School. By collecting and analyzing clinical&#xD;
      data as well as blood samples, the overall aim is to optimize TIPS therapy (e.g. specify&#xD;
      selection criteria).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 29, 2019</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Patients who die within 1 year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of (Minimal) Hepatic Encephalopathy</measure>
    <time_frame>1 year</time_frame>
    <description>Using the Portosystemic encephalopathy (PSE) syndrome test, critical flicker frequency (CFF) and animal naming test (S-ANT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Nutritional Status</measure>
    <time_frame>1 year</time_frame>
    <description>Nutritional Status will be measured by hand grip strength (dynamometer) in kg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>1 year</time_frame>
    <description>Using the questionnaire short-form 36 (SF36) (Score range 0-100, higher scores correspond to better quality of life)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory markers (e.g. cytokine)</measure>
    <time_frame>12 months</time_frame>
    <description>Different cytokines and markers of bacterial translocation (e.g. LPS) are measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in different metabolites using mass spectroscopy (metabolomics measurements)</measure>
    <time_frame>12 months</time_frame>
    <description>More than 300 metabolites will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of cellular immunity by collection of peripheral blood mononuclear cells (PBMCs)</measure>
    <time_frame>12 months</time_frame>
    <description>Fluorescence activated cell sorting (FACS) analysis, genetics and in vitro stimulation assays will be performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of stool samples</measure>
    <time_frame>12 months</time_frame>
    <description>Analysis of the intestinal microbiome and metagenome analysis (shotgun sequencing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of portal hypertension</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of the hepatic venous pressure gradient (HVPG) to ensure the efficacy of the TIPS insertion</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Decompensated Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>TIPS insertion</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TIPS insertion</intervention_name>
    <description>Patients are included in the registry if they receive a transjugular intrahepatic portosystemic shunt at Hannover Medical School and provide written informed consent.</description>
    <arm_group_label>TIPS insertion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with decompensated liver cirrhosis and an indication for TIPS placement at&#xD;
        Hannover Medical School.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Liver cirrhosis&#xD;
&#xD;
          -  Indication for TIPS insertion&#xD;
&#xD;
          -  Treatment at the Department of Gastroenterology, Hepatology and Endocrinology of&#xD;
             Hannover Medical School&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or Lactation&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
&#xD;
          -  Lack of Informed consent&#xD;
&#xD;
          -  Symptomatic anemia with Hb &lt;7g/dl&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Maasoumy, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Maasoumy, PD</last_name>
    <phone>+49 511 532-6529</phone>
    <email>Maasoumy.Benjamin@mha-hannover.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hannover</city>
        <state>Lower Saxony</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Maasoumy, PD</last_name>
      <phone>+49 511 532-6529</phone>
      <email>Maasoumy.Benjamin@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Benjamin Maasoumy, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Portal hypertension</keyword>
  <keyword>TIPS</keyword>
  <keyword>Refractory ascites</keyword>
  <keyword>Variceal bleeding</keyword>
  <keyword>Liver cirrhosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

